Growth Metrics

Mainz Biomed (MYNZ) Shares Outstanding (Diluted Average) (2020 - 2022)

Historic Shares Outstanding (Diluted Average) for Mainz Biomed (MYNZ) over the last 3 years, with Q4 2022 value amounting to $14.2 million.

  • Mainz Biomed's Shares Outstanding (Diluted Average) rose 9633.49% to $14.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $14.2 million, marking a year-over-year increase of 9633.49%. This contributed to the annual value of $14.2 million for FY2022, which is 9633.49% up from last year.
  • Per Mainz Biomed's latest filing, its Shares Outstanding (Diluted Average) stood at $14.2 million for Q4 2022, which was up 9633.49% from $7.2 million recorded in Q4 2021.
  • Over the past 5 years, Mainz Biomed's Shares Outstanding (Diluted Average) peaked at $14.2 million during Q4 2022, and registered a low of $5.6 million during Q4 2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $7.2 million (2021), whereas its average is $9.0 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first surged by 2859.95% in 2021, then skyrocketed by 9633.49% in 2022.
  • Over the past 3 years, Mainz Biomed's Shares Outstanding (Diluted Average) (Quarter) stood at $5.6 million in 2020, then rose by 28.6% to $7.2 million in 2021, then skyrocketed by 96.33% to $14.2 million in 2022.
  • Its last three reported values are $14.2 million in Q4 2022, $7.2 million for Q4 2021, and $5.6 million during Q4 2020.